A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy

Background: Each year in the UK, there are between two and nine deaths from anaphylaxis caused by bee and wasp venom. Anaphylactic reactions can occur rapidly following a sting and can progress to a life-threatening condition within minutes. To avoid further reactions in people with a history of ana...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: J Hockenhull, M Elremeli, MG Cherry, J Mahon, M Lai, J Darroch, J Oyee, A Boland, R Dickson, Y Dundar, R Boyle
Formato: Artigo
Idioma:Inglês
Publicado em: NIHR Journals Library 2012-03-01
Colecção:Health Technology Assessment
Assuntos:
pharmalgen®
immunotherapy
bee venom
wasp venom
systemic allergic reaction
high-dose antihistamine
adrenaline auto-injector
systematic review
Acesso em linha:https://doi.org/10.3310/hta16120
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados